Market Newsdesk

LOS ANGELES, Nov. 13, 2020 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 7, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Mesoblast Limited (“Mesoblast” or the “Company”) (NASDAQ: MESO) securities between April 16, 2019 and October 1, 2020, inclusive (the “Class Period”).

If you suffered a loss on your Mesoblast investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/mesoblast-limited/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Mesoblast develops allogeneic cellular medicines using its proprietary mesenchymal lineage cell therapy platform. Its lead product candidate, RYONCIL (remestemcel-L), is an investigational therapy comprising mesenchymal stem cells derived from bone marrow. In February 2018, the Company announced that remestemcel-L met its primary endpoint in a Phase 3 trial to treat children with steroid refractory acute graft versus host disease (“aGVHD”).

In early 2020, Mesoblast completed its rolling submission of its Biologics License Application (“BLA”) with the FDA to secure marketing authorization to commercialize remestemcel-L for children with steroid refractory aGVHD.

On August 11, 2020, the FDA released briefing materials for its Oncologic Drugs Advisory Committee (“ODAC”) meeting to be held on August 13, 2020. Therein, the FDA stated that Mesoblast provided post hoc analyses of other studies “to further establish the appropriateness of 45% as the null Day-28 ORR” for its primary endpoint. The briefing materials stated that, due to design differences between these historical studies and Mesoblast’s submitted study, “it is unclear that these study results are relevant to the proposed indication.”

On this news, the Company’s share price fell $6.09, or approximately 35%, to close at $11.33 per share on August 11, 2020, on unusually heavy trading volume.

On October 1, 2020, Mesoblast disclosed that it had received a Complete Response Letter (“CRL”) from the FDA regarding its marketing application for remestemcel-L for treatment of SR-aGVHD in pediatric patients. According to the CRL, the FDA recommended that the Company “conduct at least one additional randomized, controlled study in adults and/or children to provide further evidence of the effectiveness of remestemcel-L for SR-aGVHD.” The CRL also “identified a need for further scientific rationale to demonstrate the relationship of potency measurements to the product’s biologic activity.”

On this news, the Company’s stock fell $6.56, or 35%, to close at $12.03 per share on October 2, 2020, on unusually heavy trading volume.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of remestemcel-L for steroid refractory aGVHD due to design differences between the four studies; (2) as a result, the FDA was reasonably likely to require further clinical studies; (3) as a result, the commercialization of remestemcel-L in the U.S. was likely to be delayed; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Mesoblast securities during the Class Period, you may move the Court no later than December 7, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.  

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com  
[email protected]

LOS ANGELES, Nov. 13, 2020 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 4, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Precigen, Inc. (“Precigen” or the “Company”) f/k/a Intrexon Corporation (“Intrexon”) (NASDAQ: PGEN, XON) securities between May 10, 2017 and September 25, 2020, inclusive (the “Class Period”).

If you suffered a loss on your Precigen investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/precigen-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com or visit our website at www.glancylaw.com to learn more about your rights.

The Company develops technologies using synthetic biology, an evolving discipline that applies engineering principles to biological systems to enable design-based control of cellular function for a specific purpose. Its methane bioconversion platform (“MBP”) purports to convert natural gas into commercial end products, such as isobutanol for gasoline blending, 2,3 Butanediol (“2,3 BDO”) for conversion to synthetic rubber, and 1,4 Butanediol for polyester.

Between May and November 2017, the Company touted that its MBP achieved yields of 2,3 BDO at profitable levels using “current natural gas and product prices.” The Company then engaged in discussions with potential partners, including strategic and financial companies, to seize the purported $100 billion market opportunity.

However, on February 28, 2019, the Company disclosed “that there is substantial doubt about its ability to continue as a going concern” because it lacked sufficient funding for operations beyond 12 months.

On this news, the Company’s share price fell $2.91, or 36%, to close at $5.06 per share on March 1, 2019, on unusually heavy trading volume. The stock price continued to fall during the next trading session by $0.92, or 18%, to close at $4.14 per share on March 4, 2019, on unusually heavy trading volume.

Then, on August 8, 2019, after the market closed, the Company announced that it would contribute the MBP and all its associated technologies and facilities to a newly formed company called MBP Titan, LLC. Though the Company would begin with a supermajority equity stake, the Company expected “to be dilutive in this enterprise.”

On this news, the Company’s share price fell $0.67, or 8.8%, to close at $6.95 per share on August 9, 2019, on unusually heavy trading volume.

Then, on March 2, 2020, after the market closed, the Company disclosed that it had been under investigation by the SEC since October 2018 “concerning the Company’s disclosures regarding its methane bioconversion platform.”

On this news, the Company’s share price fell $0.67, or 17%, to close at $3.24 per share on March 3, 2020, on unusually heavy trading volume.

On August 10, 2020, after the market closed, the Company disclosed that it had “suspended MBP Titan’s operations” as it “assess[ed] potential next steps relating to this intellectual property and MBP Titan’s other long-lived assets.”

On this news, the Company’s share price fell $0.52, or 10%, to close at $4.60 per share on August 11, 2020, on unusually heavy trading volume.

On September 25, 2020, investors learned why the Company had not been able to capitalize the MBP, “the most valuable biotechnology ever created.” Specifically, the SEC issued a cease-and-desist order in connection with misleading statements the Company had issued in 2017: the yields from MBP had been achieved using pure methane as a feedstock, rather than natural gas as the Company had claimed. Because pure methane gas costs $650 per unit, whereas natural gas costs $3 per unit, the MBP was not producing results at commercially profitable rates.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company used pure methane, rather than natural gas, as the feedstock to achieve the reported results from its methane bioconversion platform; (2) that yields from natural gas as a feedstock were substantially lower than yields using pure methane; (3) that, due to the substantial price difference between pure methane and natural gas, pure methane was not a commercially viable feedstock; (4) that, due to the high costs of pure methane, the Company could not sustain operations of the methane bioconversion platform without pursuing financial alternatives; (5) that, due to the reduced yields from natural gas and high costs of pure methane, the Company could not find a financial or strategic partner for its methane conversion platform; (6) that, as a result of the foregoing, the Company was forced to divest its methane bioconversion platform and associated intellectual property, allowing the Company to focus on its other strategic assets; (7) that the Company was under investigation by the SEC; and (8) that, as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook. 

If you purchased or otherwise acquired the Company’s securities during the Class Period, you may move the Court no later than December 4, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.   

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com  
[email protected]

BENSALEM, Pa., Nov. 13, 2020 (GLOBE NEWSWIRE) —

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected].

GoHealth, Inc. (NASDAQ: GOCO)
IPO: July 2020
Lead Plaintiff Deadline: November 20, 2020

The complaint alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that at the time of the IPO: (1) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (2) GoHealth suffered from a higher risk of customer churn due to its unique business model and limited carrier base; (3) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Company’s concentrated carrier business model, and its efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (4) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (5) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the IPO. 

NextCure, Inc. (NASDAQ: NXTC)
Class Period: November 5, 2019 – July 14, 2020
Lead Plaintiff Deadline: November 20, 2020

Shareholders with $100,000 losses or more are encouraged to contact the firm
 

The complaint filed alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) NextCure possessed NC318 data that showed a lack of efficacy and objective responses; (2) as a result, NC318 was not, in fact, effective in treating most tumor types; (3) as a result, the NC318 application was proving to be limited (if even useful at all); (4) as a result of the foregoing, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.   

Wrap Technologies, Inc. (NASDAQ: WRTC)
Class Period: April 29, 2020 – September 23, 2020
Lead Plaintiff Deadline: November 23, 2020

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that there were limited instances in which the Company’s BolaWrap could possibly be used because it requires a minimum of 10 feet between the officer and the suspect; (2) that, as a result, the BolaWrap was reasonably unlikely to be effective in most circumstances; (3) that the LAPD sought extensions of the pilot program because they needed a larger sample size to assess the effectiveness of the BolaWrap; (4) that the LAPD had not found the BolaWrap to be useful or effective during its pilot program; (5) that, as a result, the Company had not received positive feedback from the LAPD about the BolaWrap and therefore it was unlikely that the Company would secure a sizeable contract with the LAPD; and (6) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Golar LNG Limited (NASDAQ: GLNG)
Class Period: April 30, 2020 – September 24, 2020
Lead Plaintiff Deadline: November 24, 2020

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that certain employees, including Hygo’s Chief Executive Officer, had bribed third parties, thereby violating anti-bribery policies; (2) that, as a result, the Company was likely to face regulatory scrutiny and possible penalties; (3) that, as a result of the foregoing reputational harm, Hygo’s valuation ahead of its IPO would be significantly impaired; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. 

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com

RANCHO CUCAMONGA, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — The parent company of Auto-Graphics, Inc. (A-G), Agent Information Software (AIFS) released their earnings for the third quarter of 2020, ending September 30, 2020.   AIFS’ sub-company Auto-Graphics, Inc., is an industry-leading provider of library automation software. A-G was the first to provide Cloud-based library resource sharing solutions.  

In spite of the increasing COVID-19 pandemic, AIFS reported a YTD net income of $250k with an EBITDA of $847k that represented 21.1% of sales at quarter end. Cash flow remained strong YTD as the company increased its focus on costs. AIFS reported EPS of $0.06 on weighted average shares outstanding of 4,474,577.

The company’s versatile AGent Library Software Platform continues to provide solutions that empower libraries across North America, to provide more products and services to their communities.   A-G had success in cross selling SHAREit, VERSO and MONTAGE to its existing base of customers who needed to provide enhanced services during the pandemic. In addition to company completed an important new implementation of SHAREit as part of another statewide resource sharing initiative.

About
Agent Information Software

Founded in 1950 and operating under the name Auto-Graphics, Inc. since 1969, Agent Information Software, Inc. (AIS) came about in 2010 to become Auto-Graphics, Inc. parent company. AIS develops innovative information and data management solutions for multiple platforms that are standards-compliant, built on open systems architecture and available through the Software as a Service (SaaS) hosted delivery model.

AIS’ technical ingenuity and reputation for service excellence make us a trusted partner to more than 11,000 libraries, throughout North America. Customers across multiple industries use their information and data management systems, including a range of library markets such as public, academic, school, special and consortia, and supports the needs of customers in the legal, financial, publishing, aerospace, and manufacturing markets. For more information, please visit www.agentinformationsoftware.com or www.auto-graphics.com.

FOR IMMEDIATE
RELEASE

Media Contact: Bryan Straight

Auto‐Graphics, Inc.

(909) 569‐1535

[email protected]

Boca Raton, FL, Nov. 13, 2020 (GLOBE NEWSWIRE) — Companies increasingly recognize the value of delivering their learning assets outside the four walls of the organization. These audiences can include employees outside company headquarters or in remote locations as well as non-employees, such as customers, channel partners, distributors, value-added resellers and franchisees.

Extended enterprise learning takes up a relatively small chunk of the L&D budget (60% of companies say it accounts for less than 10%), but presents a great opportunity for organizations to build their brand, improve customer relationships and generate revenue. On the whole, organizations that deliver learning to the extended enterprise are satisfied with the results they get.

“Given the large amount of extended enterprise learning, it’s remarkable that 56% of companies say their extended enterprise learning efforts are either effective or highly effective,” said Brandon Hall Group CEO Mike Cooke. “This is notable because rarely in our research do more than half of organizations rate other, more internally facing learning efforts this effective.”

“Clearly, there is room for improvement but the fact that more companies say they are effective than those saying they are only somewhat effective is impressive,” said Brandon Hall Group Principal Learning Analyst David Wentworth.

Why is this aspect of learning and development more effective than others? Click here to view Brandon Hall Groups 2020 Extended Enterprise Study Research Data Highlights, which includes the current state of extended enterprise, as well as analysis, critical questions that organizations need to answer and Brandon Hall Group’s point of view on the research.

-About Brandon Hall Group-

Brandon Hall Group is the world’s only professional-development company that provides data, research, insights and certification to Learning and Talent professionals and organizations. The best companies in the world rely on Brandon Hall Group to help create future-proof employee-development plans for the new era of work and management.

For more than 27 years, BHG empowers, recognizes and certifies excellence in organizations throughout the world, driving the development of more than 10,000,000 employees and executives. Our annual HCM Excellence Awards program was the first to recognize and celebrate organizations for learning and talent, and as the industry’s gold standard is known as the “Academy Awards of Human Capital Management.”

Brandon Hall Group’s cloud-based platform delivers evidence-based insights in Learning and Development, Talent Management, Leadership Development, Diversity and Inclusion, Talent Acquisition and HR/Workforce Management for corporate organizations and HCM solution providers.

CALGARY, Alberta, Nov. 13, 2020 (GLOBE NEWSWIRE) — Shaw Communications Inc. today announced that it is continuing to invest in British Columbia to create better retail experiences for connectivity shoppers in Vancouver, Langley, and Nanaimo.

Shaw opened the doors on its 2,025-square-foot retail store at Woodgrove Centre (6631 N Island Hwy) in Nanaimo this week. The new store in Nanaimo follows the opening of a 2,295-square-foot retail store in Langley at Willowbrook Shopping Centre (19705 Fraser Hwy) and another retail store at Shaw Tower in Vancouver (1067 West Cordova Street).

These new retail locations offer a contemporary and inviting environment for customers to explore Shaw’s latest products and services, including Shaw Mobile and Shaw Fibre+ Gig 1.5 internet and other Shaw Internet plans. For customers, the mall is often the final stop on a shopping journey that begins with online research on the wide array of products and services available to meet their heightened need for affordable and fast connectivity.

“Shopping is all about creating a positive and informative experience, and our redesigned stores are where Shaw products and services come to life,” said Paul Deverell, President, Consumer, Shaw Communications. “We’re giving residents of Vancouver, Langley, and Nanaimo a superior experience as they look to fulfill their growing need for ultrafast home internet and affordable wireless services. Our new retail spaces are stunning to look at and provide safe places for customers to get trusted advice from our connectivity experts.”

Each new store offers an immersive setting for customers to learn more about Shaw products and services — either from an expert advisor or on their own using interactive demonstration walls and digital display stations. The displays are modern, backlit and uncluttered to ensure the latest technology is front and centre so that customers get a better feel for what they are taking home while adhering to all applicable COVID-19 safety protocols.

Shaw Mobile is now available in more than 140 locations across B.C. and Alberta, including 22 Shaw retail stores, 59 Walmart stores and 52 locations of The Mobile Shop in Real Canadian Superstore and T&T Supermarket grocery stores. Future retail openings in B.C. are planned to take place at high-traffic shopping destinations in West Vancouver, Prince George, and Victoria in the coming weeks.

Shaw began its multi-million-dollar retail expansion when it launched Shaw Mobile wireless services in British Columbia and Alberta in July 2020.

In addition to making it more convenient for customers to get the connectivity services they need, Shaw’s retail efforts are contributing to each community’s economic recovery from the COVID-19 pandemic by creating jobs at a time of high unemployment and working with Canadian suppliers wherever possible.

“Shaw Communications is a top employer in our City. We are delighted to recognize Shaw for continuing to grow its presence in Nanaimo and contributing to our city’s economic development through the opening of its newest retail location,” said Leonard Krog, Mayor, Nanaimo. “This further investment will make it easier for residents to get the affordable wireless services and strong home internet connection they are looking for.”

“In these unprecedented times, people need to stay in touch and have dependable access to vital information more than ever,” said Jack Froese, Mayor, Township of Langley. “Options that keep people connected — especially with affordability in mind — are greatly appreciated, and we are pleased to see Shaw investing in our community, expanding opportunities, and providing employment.”

Customers can visit Shaw.ca/contact-us/retail for a complete list of locations.

More information, including a complete list of pricing and packaging for Shaw Internet plans, including Fibre+ Gig 1.5, and Shaw Mobile plans, can be found at shawmobile.ca/plans as well as shaw.ca/internet.

About Shaw

Shaw Communications Inc. is a leading Canadian connectivity company. The Wireline division consists of Consumer and Business services. Consumer serves residential customers with broadband Internet, Shaw Go WiFi, video and digital phone. Business provides business customers with Internet, data, WiFi, digital phone and video services. The Wireless division provides wireless voice and LTE data services through an expanding and improving mobile wireless network infrastructure.

Shaw is traded on the Toronto and New York stock exchanges and is included in the S&P/TSX 60 Index (Symbol: TSX – SJR.B, SJR.PR.A, SJR.PR.B, NYSE – SJR, and TSXV – SJR.A). For more information, please visit www.shaw.ca

Caution Regarding Forward Looking Statements

Statements included in this news release that are not historic constitute “forward looking information” within the meaning of applicable securities laws. Such statements include, but are not limited to, statements concerning Shaw’s retail expansion, the opening and timing of opening of new retail locations in British Columbia, and/or the creation of new jobs in connection with the opening of new retail locations. These statements are based on assumptions made by Shaw that it believes are appropriate and reasonable in the circumstances, including without limitation, the forbearance of governments in implementing any emergency measures or changes in laws or regulations that may impact Shaw’s products or services, such as retail store closures in response to the ongoing COVID-19 pandemic.

Undue reliance should not be placed on any forward-looking statement. Many factors, including those not within Shaw’s control, may cause actual results to be materially different from the views expressed or implied by such forward-looking statements, including but not limited to: Shaw’s ability to access key suppliers and third-party service providers and their goods and services on commercially reasonable terms; changes in the general economic, market and business conditions; emergency measures implemented by any government; changes in laws, regulations and decisions by regulators that affect Shaw products or services, or the markets in which Shaw operates; and other factors described in Shaw’s 2020 Annual Report under the heading “Known Events, Trends, Risks and Uncertainties.” The foregoing is not an exhaustive list of all possible factors. Should one or more of these risks materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein. Any forward-looking statements contained herein speak only as of the date of this news release. Except as required by law, Shaw disclaims any obligation to update any forward-looking statement.

For media inquiries, please contact:

Shaw Communications Inc.
Chethan Lakshman, VP, External Affairs
(403) 930-8448
[email protected]